Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G van der Hem

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Netherlands Journal of Medicine|September 2, 2003
Late-onset cardiotoxicity of chemotherapy and radiotherapyB Dietz, K G van der Hem
European Journal of Haematology|September 1, 1992
All-trans retinoic acid toxicityK G van der Hem, G J Ossenkoppele
The Netherlands Journal of Medicine|December 1, 1991
Late relapse of testicular cancer. A case report and a review of the literatureK G van der Hem, C J van Groeningen, H M Pinedo
The Netherlands Journal of Medicine|June 1, 1991
"Spontaneous" catheter fracture and embolization of a totally implanted venous access portK G van der Hem, S Meijer, C J Werter, et al.
Leukemia Research|September 1, 1995
Effects of bryostatin-5 and hematopoietic growth factors on acute myeloid leukemia cell differentiation, proliferation, and primary plating efficiencyK G van der Hem, A M Dräger, J H Odding, et al.
The Journal of Urology|October 1, 1992
Malignant Leydig cell tumor of the testis in complete remission on o,p'-dichlorodiphenyl-dichloroethaneK G van der Hem, E Boven, M B van Hennik, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 19, 1996
[Effective preoperative studies in outpatient anesthesiology]R J Loffeld, T Thjing Kong, K G van der Hem, et al.
Leukemia Research|September 1, 1996
Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: dose and time scheduling dependencyK G van der Hem, G J Schuurhuis, A M Dräger, et al.
Leukemia Research|January 1, 1995
Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cellsK G van der Hem, A M Dräger, J H Odding, et al.
Leukemia|February 1, 1994
The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3K G van der Hem, A M Dräger, P C Huijgens, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Netherlands Journal of Medicine|September 2, 2003
Late-onset cardiotoxicity of chemotherapy and radiotherapyB Dietz, K G van der Hem
European Journal of Haematology|September 1, 1992
All-trans retinoic acid toxicityK G van der Hem, G J Ossenkoppele
The Netherlands Journal of Medicine|December 1, 1991
Late relapse of testicular cancer. A case report and a review of the literatureK G van der Hem, C J van Groeningen, H M Pinedo
The Netherlands Journal of Medicine|June 1, 1991
"Spontaneous" catheter fracture and embolization of a totally implanted venous access portK G van der Hem, S Meijer, C J Werter, et al.
Leukemia Research|September 1, 1995
Effects of bryostatin-5 and hematopoietic growth factors on acute myeloid leukemia cell differentiation, proliferation, and primary plating efficiencyK G van der Hem, A M Dräger, J H Odding, et al.
The Journal of Urology|October 1, 1992
Malignant Leydig cell tumor of the testis in complete remission on o,p'-dichlorodiphenyl-dichloroethaneK G van der Hem, E Boven, M B van Hennik, et al.
Nederlands Tijdschrift Voor Geneeskunde|October 19, 1996
[Effective preoperative studies in outpatient anesthesiology]R J Loffeld, T Thjing Kong, K G van der Hem, et al.
Leukemia Research|September 1, 1996
Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: dose and time scheduling dependencyK G van der Hem, G J Schuurhuis, A M Dräger, et al.
Leukemia Research|January 1, 1995
Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cellsK G van der Hem, A M Dräger, J H Odding, et al.
Leukemia|February 1, 1994
The differentiation inducing effect of bryostatin 5 on human myeloid blast cells is potentiated by vitamin D3K G van der Hem, A M Dräger, P C Huijgens, et al.
Pageof 2